@DrugDiscoverDev profile picture
Drug Discovery & Development @DrugDiscoverDev

Drug Discovery & Development reports on cover #Drug introductions, formulations, pipeline candidates, #ClinicalTrial trends & #DrugDevelopments related to #AI

Joined December 2019
  • Tweets 1,938
  • Following 115
  • Followers 1,008
215 Photos and videos
Subscribe to Drug Discovery & Development for your weekly roundup of the latest strategies & technologies related to biopharma, #biotech, cell & gene therapy, and pharmaceutical R&D: drugdiscoverytrends.com/sign…
1
89
Subscribe to Drug Discovery & Development for your weekly roundup of the latest strategies & technologies related to biopharma, #biotech, cell & gene therapy, and pharmaceutical R&D: drugdiscoverytrends.com/sign…
90
Subscribe to Drug Discovery & Development for your weekly roundup of the latest strategies & technologies related to biopharma, #biotech, cell & gene therapy, and pharmaceutical R&D: drugdiscoverytrends.com/sign…
81
From monoclonal antibodies to CAR T, oncology biosimilars face scientific, regulatory, and adoption challenges. Learn how sponsors can prepare: drugdiscoverytrends.com/what…
75
Beyond approvals, uptake of biosimilars depends on education, real-world data, and trusted communication with providers and patients. drugdiscoverytrends.com/what…
70
Physician buy-in is essential for oncology biosimilar adoption. Misconceptions about quality and trial rigor persist—here’s how to address them: drugdiscoverytrends.com/what…
53
Subscribe to Drug Discovery & Development for your weekly roundup of the latest strategies & technologies related to biopharma, #biotech, cell & gene therapy, and pharmaceutical R&D: drugdiscoverytrends.com/sign…
54
Single‑use pump innovation: integrated bypass systems bring built-in pressure relief and seamless recirculation—no external components needed. Discover how it's shaping biopharma design: drugdiscoverytrends.com/adva…
49
As biosimilars for cell therapies like CAR T emerge, questions remain: can regulatory bodies accept similarity in inherently unique therapies? drugdiscoverytrends.com/what…
45
Add pressure resilience to your biopharma workflows. Integrated bypass in single‑use pumps ensures automatic recirculation and avoids process interruptions. Read more: drugdiscoverytrends.com/adva…
40
Recruiting patients for oncology biosimilar trials is harder than it seems—especially when the originator drug is already approved and accessible. drugdiscoverytrends.com/what…
37
The 2025 Pharma 50 Deep Dives report goes beyond the rankings, identifying high-momentum drugs, tracking major decliners, analyzing biosimilar-driven market erosion, and examining the regulatory pressures shaping 2025. Access the free report: drugdiscoverytrends.com/the-…
49
Looking to bypass pressure-related failures? Next-gen single-use pumps integrate bypass circuits that trigger under overpressure—boosting safety and uptime. Learn more: drugdiscoverytrends.com/adva…
50
Elevate your single‑use pump design: integrated bypass provides automatic flow recirculation during back‑pressure events—improving lifespan and system resilience. Details here: drugdiscoverytrends.com/adva…
46
Monoclonal antibody biosimilars are growing—but ensuring consistent quality remains difficult due to manufacturing sensitivity and variability. drugdiscoverytrends.com/what…
48
Biopharmaceutical systems demand both simplicity and safety. Integrated bypass in single‑use pumps delivers both—protecting systems while keeping setup lean. Read how: drugdiscoverytrends.com/adva…
45
Patent expirations open doors for oncology biosimilars, but complex modalities like ADCs, BsAbs, and CAR T cell therapies raise the bar. Explore why: drugdiscoverytrends.com/what…
40
Single‑use pumps now offer adjustable bypass systems that preserve flow control and reduce back-pressure—without external valves or complex piping. Explore the benefits: drugdiscoverytrends.com/adva…
33
When pressure spikes arise, integrated bypass technology acts fast—recirculating flow automatically, protecting costly process systems. Discover how: drugdiscoverytrends.com/adva…
34
Oncology biosimilars can dramatically lower cancer treatment costs—but developing them is far from simple. Learn what makes them uniquely challenging: drugdiscoverytrends.com/what…
31
Load more